Evidence map›Paper›PMID 42654028›Full record

ArticlePharmaceutics2026

Effect of Alkyl Chain Length on Physicochemical and Pharmacokinetic Performance of Aripiprazole Fatty Acid Prodrugs for Long-Acting Injectable Suspensions.

An Chen, Cong Lai, Hao Zhai, Shiyang Zhang, Yijing Zhang, Ting Cai

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

An ChenState Key Laboratory of Natural Medicines, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing 211198, China.
Cong LaiDepartment of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
Hao ZhaiState Key Laboratory of Natural Medicines, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing 211198, China.
Shiyang ZhangState Key Laboratory of Natural Medicines, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing 211198, China.
Yijing ZhangState Key Laboratory of Natural Medicines, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing 211198, China.
Ting CaiState Key Laboratory of Natural Medicines, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing 211198, China.ORCID 0000-0001-7510-9295

Funding

Jiangsu Province Frontier Technology Research Program BF2024075Lingang Laboratory LGL-2613-03National Natural Science Foundation of China 22478439National Natural Science Foundation of China 22508422National Natural Science Foundation of China 82273880
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

aripiprazolechain lengthfatty acidlong-acting injectable aqueous suspensionsprodrug

Identifiers

PMID42654028
PMCPMC13516184

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.